Genetic studies in idiopathic short stature

被引:23
作者
Attie, KM [1 ]
机构
[1] Genentech Inc, Dept Med Affairs, S San Francisco, CA 94080 USA
关键词
D O I
10.1097/00008480-200008000-00021
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Idiopathic short stature (ISS) refers to a heterogeneous group of children with marked growth failure of unknown cause, and encompasses familial short stature and constitutional delay of growth. It has been postulated that specific genetic mutations may explain certain cases of growth failure. Some patients with growth hormone (GH) deficiency have mutations in the GH-releasing hormone receptor or GH gene, whereas patients with GH insensitivity syndrome have mutations in the GH receptor or insulin-like growth factor-1 gene. it appears that heterozygous mutations of the GH receptor may cause partial GH insensitivity in a subset of patients with ISS. Defects in the short stature homeobox-containing gene (SHOX) in the pseudoautosomal region of the sex chromosomes may cause the growth failure seen in the Leri-Weill and Turner syndromes, and in some familial cases of ISS. Further research into stature-related genes will likely contribute to our understanding of this population. Curr Opin Pediatr 2000, 12:400-404 (C) 2000 Lippincott Williams & Wilkins Inc.
引用
收藏
页码:400 / 404
页数:5
相关论文
共 35 条
[1]   EVIDENCE FOR PARTIAL GROWTH-HORMONE INSENSITIVITY AMONG PATIENTS WITH IDIOPATHIC SHORT STATURE [J].
ATTIE, KM ;
CARLSSON, LMS ;
RUNDLE, AC ;
SHERMAN, BM .
JOURNAL OF PEDIATRICS, 1995, 127 (02) :244-250
[2]  
ATTIE KM, 1997, J PEDIAT S, V131, P56
[3]   A dominant-negative mutation of the growth hormone receptor causes familial short stature [J].
Ayling, RM ;
Ross, R ;
Towner, P ;
VonLaue, S ;
Finidori, J ;
Moutoussamy, S ;
Buchanan, CR ;
Clayton, PE ;
Norman, MR .
NATURE GENETICS, 1997, 16 (01) :13-14
[4]   Mutations in the growth hormone releasing hormone receptor: a new form of dwarfism in humans [J].
Baumann, G .
GROWTH HORMONE & IGF RESEARCH, 1999, 9 :24-29
[5]   SHOX mutations in dyschondrosteosis (Leri-Weill syndrome) [J].
Belin, V ;
Cusin, V ;
Viot, G ;
Girlich, D ;
Toutain, A ;
Moncla, A ;
Vekemans, M ;
Le Merrer, M ;
Munnich, A ;
Cormier-Daire, V .
NATURE GENETICS, 1998, 19 (01) :67-69
[6]   Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone [J].
Binder, G ;
Schwarze, CP ;
Ranke, MB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :245-249
[7]   Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion [J].
Camacho-Hübner, C ;
Woods, KA ;
Miraki-Moud, F ;
Hindmarsh, PC ;
Clark, AJ ;
Hansson, Y ;
Johnston, A ;
Baxter, RC ;
Savage, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1611-1616
[8]   REDUCED CONCENTRATION OF SERUM GROWTH HORMONE-BINDING PROTEIN IN CHILDREN WITH IDIOPATHIC SHORT STATURE [J].
CARLSSON, LMS ;
ATTIE, KM ;
COMPTON, PG ;
VITANGCOL, RV ;
MERIMEE, TJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1325-1330
[9]   Signal transduction defects in growth hormone insensitivity [J].
Clayton, PE ;
Freeth, JS ;
Whatmore, AJ ;
Ayling, RM ;
Norman, MR ;
Silva, CM .
ACTA PAEDIATRICA, 1999, 88 :174-178
[10]  
Clayton PE, 1999, CLIN ENDOCRINOL, V50, P275